Literature DB >> 16373240

Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.

John B Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16373240     DOI： 10.1080/00313020500368279

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  4 in total

Review 1.  Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Authors:  Esmée J Grobbee; Pieter Ha Wisse; Eline H Schreuders; Aafke van Roon; Leonie van Dam; Ann G Zauber; Iris Lansdorp-Vogelaar; Wichor Bramer; Sarah Berhane; Jonathan J Deeks; Ewout W Steyerberg; Monique E van Leerdam; Manon Cw Spaander; Ernst J Kuipers
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

2.  Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme.

Authors:  S Ciatto; F Martinelli; G Castiglione; P Mantellini; T Rubeca; G Grazzini; A G Bonanomi; M Confortini; M Zappa
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640

3.  Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?

Authors:  G Grazzini; C B Visioli; M Zorzi; S Ciatto; F Banovich; A G Bonanomi; A Bortoli; G Castiglione; L Cazzola; M Confortini; P Mantellini; T Rubeca; M Zappa
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

4.  Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme.

Authors:  G Castiglione; C B Visioli; S Ciatto; G Grazzini; A G Bonanomi; T Rubeca; P Mantellini; M Zappa
Journal:  Br J Cancer       Date:  2007-04-24       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.